Organisation paid for research Program year 2023 Source: CMS Open Payments

Dermresearch Inc

Neither a doctor nor a teaching hospital

Research payments

$1,910,245

202 payments

Through program year 2023, Dermresearch Inc is reported as receiving $1,910,245 in research payments, across 202 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$12,396	5
2022	Research	$44,711	11
2021	Research	$200,739	27
2020	Research	$652,330	61
2019	Research	$1,000,068	98

Breakdown

Who paid Research payments · program years 2019–2023

Allergan Inc. $941,145 69 payments
Aclaris Therapeutics, Inc. $593,961 46 payments
Bausch Health US, LLC $202,825 26 payments
LEO Pharma AS $108,577 37 payments
Endo Pharmaceuticals Inc. $28,139 9 payments
Pfizer Inc. $19,811 5 payments
AbbVie, Inc. $15,787 10 payments

Studies the money was for Research payments · program years 2019–2023

A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Twice A Week in Subjects With Common Warts $514,097 20 payments
A randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy in subjects with glabellar frown lines $438,638 16 payments
Ph 3 Pivotal LCL and GL+ LCL - US/EU $204,489 14 payments
Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Efficacysafety Study $87,266 9 payments
Ph 3 Open-label Extension Study $79,625 12 payments
Ph 3 Pivotal LCL and GL+ LCL - US/EU $70,019 5 payments
BOTOX onabotulinumtoxinA Treatment of Masseter Muscle Prominence A Phase 2b, Multicenter, Randomized, Double Blind, Multi-Dose, Placebo-Controlled Study $68,143 7 payments
A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Clinical Study to Compare the Safety and Efficacy of Idp-126 Gel to Epiduo? Forte Gel (0.3% Adapalene/2.5% Bpo), in the Treatment of Acne Vulgaris $59,099 8 payments
Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Efficacy and Safety of Idp-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects $56,460 9 payments
BOTOX (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence: A Phase 2b, Multicenter, Randomized, Double Blind, Multi-Dose, Placebo-Controlled Study $52,661 12 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.